Global Mammalian Transient Protein Expression Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Mammalian Transient Protein Expression Market Insights, Forecast to 2034
The use of mammalian transient protein expression in quick production of proteins continues to spur developments. The capability of mammalian cells to aid development of proteins with similar bioactivity as natural proteins continues to boost their adoption.
Market Analysis and InsightsGlobal Mammalian Transient Protein Expression Market
Global Mammalian Transient Protein Expression market is expected to reach to US$ 697 million in 2023, with a positive growth of %, compared with US$ 681 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Mammalian Transient Protein Expression industry is evaluated to reach US$ 1112.2 million in 2033. The CAGR will be 8.1% during 2023 to 2033.
The Mammalian Transient Protein Expression market is driven by the increasing demand for recombinant proteins for various research, therapeutic, and diagnostic applications. Mammalian expression systems offer advantages like proper folding, post-translational modifications, and scalability, making them ideal for producing functional proteins. This drives the demand for efficient transient protein expression technologies that enable rapid and high-yield protein production for early-stage research and development. Additionally, advancements in genetic engineering and bioprocessing techniques have improved the efficiency and ease of transient protein expression. However, challenges include optimization of expression conditions, variability in protein yields, and high production costs. Developing improved expression vectors, media formulations, and purification techniques are crucial for addressing these challenges and driving the market's growth. The ability to produce high-quality proteins quickly and cost-effectively is pivotal for researchers and industries engaged in drug development, diagnostics, and other biotechnological applications, thereby shaping the trajectory of the Mammalian Transient Protein Expression market.
Report Covers
This report presents an overview of global Mammalian Transient Protein Expression market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Mammalian Transient Protein Expression market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Thermo Fisher Scientific
Merck
Lonza
Agilent Technologies
Takara Bio
Mirus Bio
Bio-Rad Laboratories
Qiagen
HiMedia Laboratories
Promega Corporation
Sino Biological
Segment by Type
Instruments
Expression Vector
Reagents & Consumables
Other
Contract Research Organization
Biopharmaceutical Companies
Academic & Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Mammalian Transient Protein Expression introduction, etc. Mammalian Transient Protein Expression Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Mammalian Transient Protein Expression
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Mammalian Transient Protein Expression Market
Global Mammalian Transient Protein Expression market is expected to reach to US$ 697 million in 2023, with a positive growth of %, compared with US$ 681 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Mammalian Transient Protein Expression industry is evaluated to reach US$ 1112.2 million in 2033. The CAGR will be 8.1% during 2023 to 2033.
The Mammalian Transient Protein Expression market is driven by the increasing demand for recombinant proteins for various research, therapeutic, and diagnostic applications. Mammalian expression systems offer advantages like proper folding, post-translational modifications, and scalability, making them ideal for producing functional proteins. This drives the demand for efficient transient protein expression technologies that enable rapid and high-yield protein production for early-stage research and development. Additionally, advancements in genetic engineering and bioprocessing techniques have improved the efficiency and ease of transient protein expression. However, challenges include optimization of expression conditions, variability in protein yields, and high production costs. Developing improved expression vectors, media formulations, and purification techniques are crucial for addressing these challenges and driving the market's growth. The ability to produce high-quality proteins quickly and cost-effectively is pivotal for researchers and industries engaged in drug development, diagnostics, and other biotechnological applications, thereby shaping the trajectory of the Mammalian Transient Protein Expression market.
Report Covers
This report presents an overview of global Mammalian Transient Protein Expression market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Mammalian Transient Protein Expression market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher Scientific
Merck
Lonza
Agilent Technologies
Takara Bio
Mirus Bio
Bio-Rad Laboratories
Qiagen
HiMedia Laboratories
Promega Corporation
Sino Biological
Segment by Type
Instruments
Expression Vector
Reagents & Consumables
Other
Segment by Application
Contract Research Organization
Biopharmaceutical Companies
Academic & Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Mammalian Transient Protein Expression introduction, etc. Mammalian Transient Protein Expression Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Mammalian Transient Protein Expression
Chapter 13Methodology and Data Sources adopted by MRAResearch